Lung cancer is the leading cause of cancer-related mortality worldwide. Low-dose CT (LDCT) lung cancer screening (LCS) reduces lung cancer-specific mortality by 20%, yet participation remains low, often below 15%, compared with 60–75% for other cancer screening programmes.

Barriers

Barriers such as limited accessibility, stigma, fear of diagnosis, and misconceptions contribute to poor uptake, particularly among high-risk groups, including heavy smokers, ethnic minorities, and individuals from lower socioeconomic backgrounds. Various recruitment strategies—such as personalised invitations, media campaigns, and primary care referrals—have been implemented, but their effectiveness across different populations remains unclear.

This umbrella review will synthesise evidence from systematic reviews to identify the most effective recruitment strategies for improving LCS participation.

Read the full paper:
👉 https://hrbopenresearch.org/articles/8-71/v1